Navigation Links
PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund

SAN CARLOS, Calif., Dec. 27, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company, today announced a $10 million round of equity financing from Founders Fund and the addition of Founders Fund partner Ken Howery to its Board of Directors.  

PharmacoFore uses innovative synthetic organic chemistry to create novel medicines for treating a variety of conditions related to the central and peripheral nervous systems.  One of its key platform technologies has generated a series of novel molecules that it believes will facilitate prevention of the abuse and misuse of prescription drugs -- now the leading cause of accidental death in the United States, surpassing auto-related fatalities. 

Wes Sterman, CEO of PharmacoFore, Inc., commented, "We are thrilled to have the enthusiastic support of Founders Fund as we advance our pipeline, along with partners, to regulatory approval and commercialization throughout the world." 

Ken Howery is a co-founder of PayPal and served as the company's first CFO prior to its initial public offering and subsequent sale to eBay.  Before launching Founders Fund, Ken Howery was a member of the research and trading teams at Clarium Capital Management.

Founders Fund investment philosophy is distinguished by its focus on innovative, cost-effective companies that can capture multi-billion dollar markets through transformational technologies that can lead to positive change in the world.

About Founders Fund
Founders Fund provides capital to transformational businesses run by world-class entrepreneurs. Companies the firm has backed include Facebook (managing partner Peter Thiel was Facebook's first outside backer), Quantcast, SpaceX, Palantir Technologies, RoboteX, Spotify, Yammer,, and Slide. The firm, which pursues a founder-friendly investment strategy, is overseen by four managing partners, all of whom have founded companies worth more than $1 billion: Peter Thiel (PayPal); Ken Howery (PayPal); Luke Nosek (PayPal); and Sean Parker (Napster; Plaxo, Causes; founding president, Facebook).

About PharmacoFore, Inc.
PharmacoFore, Inc., is a privately held biopharmaceutical company focused on creating novel medicines that provide clear clinical benefits over existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications.  

PharmacoFore, Inc. Contact:
A. Gregory Sturmer
VP, Finance and Chief Financial Officer

Media Contact:
Tiberend Strategic Advisors, Inc.
Jason Rando / Andrew Mielach /


SOURCE PharmacoFore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
2. AuraSense Therapeutics Secures Series B Equity Investment
3. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
4. ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders
5. Awarepoint Corporation Secures $27 Million in New Financing: Kleiner Perkins Caufield & Byers Leads Round
6. NeurogesX, Inc. Secures $20 Million Debt Facility
7. Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
8. SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited by Surgeons as The Future of Minimally Invasive Surgery
9. Digital Assent Secures $7.5 Million Series B Funding
10. Precyse Secures Healthcare IT Executive Chris Powell as New President
11. Ethicon, Inc. Announces Availability of ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 26, 2015 , ... ... (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public R&D ... Nairobi (UNON) for the opening of the 5th African Network for Drugs and ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... encouraging people across the country to celebrate their sobriety and show through pictures ... post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... Crystal Lake, IL (PRWEB) , ... November 25, 2015 , ... ... pleased to announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto ... the case Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , ...
Breaking Medicine News(10 mins):